168 related articles for article (PubMed ID: 33400734)
1. Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14.
Dejure FR; Butzer J; Lindemann RK; Mardin BR
Oncotarget; 2020 Dec; 11(48):4490-4503. PubMed ID: 33400734
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer.
Babu E; Bhutia YD; Ramachandran S; Gnanaprakasam JP; Prasad PD; Thangaraju M; Ganapathy V
Biochem J; 2015 Jul; 469(1):17-23. PubMed ID: 26173258
[TBL] [Abstract][Full Text] [Related]
3. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.
Karunakaran S; Ramachandran S; Coothankandaswamy V; Elangovan S; Babu E; Periyasamy-Thandavan S; Gurav A; Gnanaprakasam JP; Singh N; Schoenlein PV; Prasad PD; Thangaraju M; Ganapathy V
J Biol Chem; 2011 Sep; 286(36):31830-8. PubMed ID: 21771784
[TBL] [Abstract][Full Text] [Related]
4. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.
Coothankandaswamy V; Cao S; Xu Y; Prasad PD; Singh PK; Reynolds CP; Yang S; Ogura J; Ganapathy V; Bhutia YD
Br J Pharmacol; 2016 Dec; 173(23):3292-3306. PubMed ID: 27747870
[TBL] [Abstract][Full Text] [Related]
5. SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.
Sikder MOF; Sivaprakasam S; Brown TP; Thangaraju M; Bhutia YD; Ganapathy V
Biochem J; 2020 Apr; 477(8):1409-1425. PubMed ID: 32219372
[TBL] [Abstract][Full Text] [Related]
6. Trafficking to the Cell Surface of Amino Acid Transporter SLC6A14 Upregulated in Cancer Is Controlled by Phosphorylation of SEC24C Protein by AKT Kinase.
Kovalchuk V; Nałęcz KA
Cells; 2021 Jul; 10(7):. PubMed ID: 34359969
[TBL] [Abstract][Full Text] [Related]
7. SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.
Sniegowski T; Korac K; Bhutia YD; Ganapathy V
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806675
[TBL] [Abstract][Full Text] [Related]
8. Amino Acid Transporter SLC6A14 (ATB
Nałęcz KA
Front Cell Dev Biol; 2020; 8():594464. PubMed ID: 33195271
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer.
Schniers BK; Wachtel MS; Sharma M; Korac K; Rajasekaran D; Yang S; Sniegowski T; Ganapathy V; Bhutia YD
Biochem J; 2022 Mar; 479(5):719-730. PubMed ID: 35212370
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14.
McCracken AN; Edinger AL
Biochem J; 2015 Sep; 470(3):e17-9. PubMed ID: 26341486
[TBL] [Abstract][Full Text] [Related]
11. SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity
Mercier J; Calmel C; Mésinèle J; Sutanto E; Merabtene F; Longchampt E; Sage E; Kicic A; Boëlle PY; Corvol H; Ruffin M; Guillot L
Front Mol Biosci; 2022; 9():850261. PubMed ID: 35372502
[TBL] [Abstract][Full Text] [Related]
12. Pre-steady-state Kinetic Analysis of Amino Acid Transporter SLC6A14 Reveals Rapid Turnover Rate and Substrate Translocation.
Shi Y; Wang J; Ndaru E; Grewer C
Front Physiol; 2021; 12():777050. PubMed ID: 34867484
[TBL] [Abstract][Full Text] [Related]
13. Regulation of SLC6A14 trafficking in breast cancer cells by heat shock protein HSP90β.
Połosak K; Papierniak-Wyglądała A; Nałęcz KA
Biochem Biophys Res Commun; 2022 Jul; 614():41-46. PubMed ID: 35569376
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
[TBL] [Abstract][Full Text] [Related]
15.
Di Paola M; Park AJ; Ahmadi S; Roach EJ; Wu YS; Struder-Kypke M; Lam JS; Bear CE; Khursigara CM
mBio; 2017 Dec; 8(6):. PubMed ID: 29259090
[TBL] [Abstract][Full Text] [Related]
16. The Na
Sikder MOF; Yang S; Ganapathy V; Bhutia YD
AAPS J; 2017 Dec; 20(1):12. PubMed ID: 29204754
[TBL] [Abstract][Full Text] [Related]
17. Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14.
Jo H; Lee D; Go C; Jang Y; Bae S; Agura T; Hong J; Kang D; Kim Y; Kang JS
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625849
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer.
Bacci M; Lorito N; Ippolito L; Ramazzotti M; Luti S; Romagnoli S; Parri M; Bianchini F; Cappellesso F; Virga F; Gao Q; Simões BM; Marangoni E; Martin LA; Comito G; Ferracin M; Giannoni E; Mazzone M; Chiarugi P; Morandi A
Cell Rep; 2019 Jul; 28(1):104-118.e8. PubMed ID: 31269432
[TBL] [Abstract][Full Text] [Related]
19. Resetting amino acid metabolism of cancer cells by ATB
Kou L; Jiang X; Tang Y; Xia X; Li Y; Cai A; Zheng H; Zhang H; Ganapathy V; Yao Q; Chen R
Bioact Mater; 2022 Mar; 9():15-28. PubMed ID: 34820552
[TBL] [Abstract][Full Text] [Related]
20. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma.
Yun H; Lee M; Kim SS; Ha J
J Biol Chem; 2005 Mar; 280(11):9963-72. PubMed ID: 15640157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
